Changeflow GovPing Healthcare & Life Sciences Dassault Systemes Patent, Predicting Newborn Ca...
Routine Rule Added Final

Dassault Systemes Patent, Predicting Newborn Cardiovascular Behavior from Fetus Parameters

Favicon for changeflow.com USPTO Patent Applications - Health Informatics (G16H)
Published
Detected
Email

Summary

Dassault Systemes has obtained US Patent Application US20260112490A1, published April 23, 2026, covering a computer-implemented method for predicting cardiovascular behavior of a newborn at birth from fetus physiological parameters. The method involves obtaining fetus physiological data, applying a non-calibrated surrogate cardiovascular model, calibrating the model using data assimilation algorithms, and triggering physiological birth changes to predict newborn cardiovascular behavior. The application (No. 19362244) was filed October 17, 2025, with inventors Hernán Morales Varela and Philipp Christoph Weder.

“A computer-implemented method for predicting a cardiovascular behavior of a newborn to birth from his/her fetus physiological parameters.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 146 changes logged to date.

What changed

Dassault Systemes has secured US Patent Application US20260112490A1 for a computer-implemented method that predicts cardiovascular behavior of a newborn at birth from fetus physiological parameters. The method comprises: (1) obtaining physiological parameters of the fetus, (2) obtaining a non-calibrated surrogate cardiovascular model, (3) calibrating the model using data assimilation algorithms with the fetus parameters, and (4) triggering physiological birth changes in the calibrated model to predict newborn cardiovascular behavior. The patent covers G16H classifications related to health informatics, specifically targeting cardiovascular modeling for birth prediction.

For affected parties, this patent grants Dassault Systemes enforceable intellectual property rights in the US for fetal-to-newborn cardiovascular prediction technology. Competitors developing similar computer-implemented methods for perinatal cardiovascular modeling should review this patent landscape to assess freedom-to-operate. Healthcare technology companies and medical device manufacturers in the fetal monitoring space may need to evaluate whether their products or methods fall within the scope of these claims.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PREDICTING A CARDIOVASCULAR BEHAVIOR OF A NEWBORN TO BIRTH FROM THE FETUS PHYSIOLOGICAL PARAMETERS OF THE NEWBORN TO BIRTH

Application US20260112490A1 Kind: A1 Apr 23, 2026

Assignee

DASSAULT SYSTEMES

Inventors

Hernán MORALES VARELA, Philipp Christoph WEDER

Abstract

A computer-implemented method for predicting a cardiovascular behavior of a newborn to birth from his/her fetus physiological parameters. The method comprises obtaining physiological parameters of the fetus, obtaining a non-calibrated surrogate cardiovascular model modeling a cardiovascular system of the fetus and modelling at least one physiological change triggered by the birth, calibrating the non-calibrated surrogate cardiovascular model with a data assimilation algorithm using the obtained physiological parameters of the fetus on the non-calibrated surrogate cardiovascular model, thereby obtaining a calibrated surrogate cardiovascular model of the fetus, and predicting the cardiovascular behavior of the newborn by triggering the at least one physiological change of the calibrated surrogate cardiovascular model of the fetus, thereby obtaining a calibrated surrogate cardiovascular model of the newborn.

CPC Classifications

G16H 50/20 A61B 34/10 G16H 10/60 G16H 50/50 G16H 50/70 A61B 2034/105

Filing Date

2025-10-17

Application No.

19362244

View original document →

Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260112490A1

Who this affects

Applies to
Medical device makers Manufacturers
Industry sector
5112 Software & Technology
Activity scope
Patent filing IP licensing Medical device software
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Regulatory Affairs
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!